New Guidelines for Prescribing Opioids

Similar documents
CDC Guideline Impact

CDC Opioid Prescribing Guidelines

Opioids drive continued increase in drug overdose deaths

Managing Narcotics on Workers Comp Claims. Presented By: Craig S. Stern, PharmD, MBA President Pro Pharma Pharmaceutical Consultants, Inc.

``Considerations for using opioid drug therapy in workers compensation include patient safety, drug effectiveness and financial impacts

Medicare Part D Opioid Policies for 2019 Information for Patients

CONFRONTING THE OPIOID EPIDEMIC. e-book: Introducing OptumRx Opioid Risk Management

20/0.8mg, 30/1.2mg, Films 90 MME/day Belbuca (buprenorphine) 75mcg, 150mcg, 300mcg, 450mcg 60 units per 90 days

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists

2016 Drug Trends Series

Welcome - we will begin the webinar shortly Please read the participation tips below:

Opioid epidemic and PEHP

The Epidemiology of Opioid Abuse Thomas Dobbs, MD, MPH 6/30/2017

Pennsylvania Prescription Drug Monitoring Program Trends,

A nation in pain: Focus on Medicaid

The STOP Measure. Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018

Interventions in Prescription Opioid Abuse Do (or can) Prescription Monitoring Programs Make a Difference?

How many tramadol hcl 50 mg to get high

Opioid Analgesics. Recommended starting dose for opioid-naïve patients

OPIOID OVERDOSE EPIDEMIC: What Healthcare Providers Need to Know

CDC s Efforts to End the Opioid Epidemic

As a self-insured employer, one of your biggest challenges and potentially one of the

JOIN IN AN UNPRECEDENTED STATEWIDE MOVEMENT TO CHANGE HEALTHCARE

Prescription Drugs MODULE 5 ALLIED TRADES ASSISTANCE PROGRAM. Preventative Education: Substance Use Disorder

9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A

Shining a Light on MEDs Understanding morphine equivalent dose

Opioid Prescribing Guidelines for Patients in the Emergency Department

Opioid Analgesics with Abuse- Deterrent Properties: Current Data and Future Opportunities

Opiate Use among Ohio Medicaid Recipients

Opioids, Extended Release (ER) Quantity Limit Criteria Program Summary

OPIOID CRISIS: A PERSPECTIVE. Karl J. Haake, MD

Article #2 Prescription Drug Overdose CDC: Centers for Disease Control and Prevention. Understanding the Epidemic

Michael M. Miller, MD, FASAM, FAPA

Understanding the US Opioid Analgesic Market

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

SUBHEAD GOES HERE. Addressing Tennessee s Opioid Crisis. Natalie A. Tate, PharmD Vice President, Pharmacy

MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2018 (2018Q3)

Naloxone and Combating the Opioid Epidemic

Top 10 narcotic pain pills

EXTENDED RELEASE OPIOID DRUGS

Dr. Smith. Roneet Lev, MD FACEP Chief, Emergency Department Scripps Mercy Hospital Chair, San Diego Prescription Drug Abuse Medical Task Force

15 mg morphine 10 mg hydrocodone

The Challenge of Treating Pain

Tracker e-prescribing 101. The Complete Guide

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

Understanding the Opioid Crisis: What s at the Heart of the Matter?

Prior Authorization for Opioid Products Indicated for Pain Management

The Role of the PDMP: Foundational Knowledge and Best Practices

Opioids and Older Adults

University of Pittsburgh

Campus Narcan Project OPIOID OVERDOSE FIRST RESPONDER TRAINING

Presenters & disclosures

Opioid Review and MAT Clinic CDC Guidelines

Montgomery County Poisoning Death Review

Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD

YOUTH OPIOID ABUSE PREVENTION TOOLKIT

The Opioid Epidemic and How It is Impacting the Workplace. July 24, 2018

The Epidemiology of Opioid Abuse. Thomas Dobbs, MD, MPH Mississippi State Department of Health

Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic. October 25, 2017

Effect of Abuse-Deterrent Formulations and IR Opioids on Abuse, Overdose and Death from Rx Opioids

Increase in Opioid Related Deaths What the Data Can Tell us. Ontario Methadone Prescriber s Conference November 7, 2014 Tara Gomes

Prescription Opioid Overdose in Oregon: A public health perspective

Prior Authorization Opioid Overutilization 2017

Prescribing Opioids in the Opioid Epidemic. Scott Woffinden, PA-C Jason Chapman, JD

Managing Opioid Overutilization Challenges

Prior Authorization Guideline

Session 7: Opioids and Club Drugs 7-1

The Morbidity and Mortality of Kansas Drug Epidemic

Opioid Analgesic Treatment Worksheet

Oregon ACEP Opioid Prescribing Guidelines. Why are we talking about this?

Opioid Crisis: HHS Strategy and Advancing Pain Management

Opioid Analgesic Treatment Worksheet

INFORMATION BRIEF. Overview. Prescription Drug Abuse Among Young People

The Population is Abusing Drugs, but are Drugs Abusing Insurance?

Responding to the Opioid Addiction Epidemic

AHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion

Cigna Drug and Biologic Coverage Policy

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Opioid Addiction Statistics

Opioid Review and MAT Clinic Comorbidities Associated with Opioid Overdose

PRESCRIPTION DRUG MONITORING PROGRAM

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

Prescription Drug Abuse and Heroin: Impact on Oregon s Youth and Young Adults

New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

The Latest Prescription Trends for Controlled Prescription Drugs

: Opioid Quantity Limits

Reducing Opioid Deaths: Arizona s Emergency Declaration & Response

STATEMENT FOR THE RECORD. Submitted to the. Senate Committee on Health, Education, Labor, & Pensions

Public Policy and Best Practices for Reducing Opioid Harm. State Capital Building, Harrisburg PA June 6, 2018

Morphine er to oxycontin conversion

Opioids: What You Should Know About Opioid Prescribing. Denis G. Patterson, DO Nevada State Medical Association October 19, 2016

Do your Part Be the Solution

HEALTH INFORMATION TECHNOLOGY: A POWERFUL TOOL IN ATTACKING THE OPIOID CRISIS PAUL L. UHRIG CHIEF ADMINISTRATIVE, LEGAL & PRIVACY OFFICER

See Important Reminder at the end of this policy for important regulatory and legal information.

HEALTHCARE AND THE OPIOID EPIDEMIC DAN MUSE, MD SIGNATURE HEALTHCARE-BROCKTON HOSPITAL

See Important Reminder at the end of this policy for important regulatory and legal information.

The Prescription Opioid and Heroin Crisis: Responding to An Epidemic of Addiction

Transcription:

New Guidelines for Prescribing Opioids Keeping Your Claimants Safe Presented by: Dr. Mitch Freeman, Pharm.D. Chief Clinical Officer, Pharmacy Solutions

Agenda The Opioid Challenge Today How We Got Here National Response CDC Guidelines Impact and Recommendations

Addiction in America Today

Opioid Epidemic 259 Million Opioid Prescriptions in 12 = 1 Bottle for Every Adult in the US

Opioid Epidemic 2014 Record Number of Drug Deaths 61% from Opioids

Opioid Epidemic Every 19 Minutes Someone Dies from Opioid Abuse

Opioid Epidemic in Workers Compensation $6B Spent in WC on Prescription Drugs 50% For Pain Management 70% of Those are Opioids

How Did We Get Here?

How Did We Get Here? Portenoy, less than 1% of patients prescribed opioids for chronic pain become addicted. Pain, 1986

How Did We Get Here? Conflict of Interest? Portenoy received grant funding from...

How Did We Get Here? Misleading Physicians No Studies Support Effectiveness of Opioids Risk of Addiction was Actually Greater $600 million in fines

National Impact Opioid Overdoses Heroin is cheaper and easier to get 4/5 New Heroin Users Started with Opioids 2000 2013 6% Annual Increase 37% Annual Increase

Regulations Common Factors Frequency + Amounts Increasingly Restrictive

Disparity Guidelines 50 MED 80 MED 100 MED

Daily Dosage Contraction MED CDC Recommendations Continues to Decrease MED Recommendations 140 120 100 80 120 100 90 60 40 50 20 0 2012 2016

Tackling Opioid Abuse is as important as combating the threat of terrorism.

Outcome-CDC Guidelines CDC Guideline Highlights 1. Prescribe no more than needed 2. Use immediate release opioids to start 3. Assess risks with >50 MED Avoid >90 MED 4. Start low, Go slow, Do not prescribe ER/LA 5. Avoid concurrent benzodiazepine and opioids

Mitchell Review Mitchell Workers Compensation Opioid Review 2016

Mitchell Review Reviewed 3.9 Million Prescriptions 815K Claimants DOI After 06.01.11 Applied CDC Guidelines

CDC Guidelines Guideline 1 Prescribe no more than needed 3 days or less Rarely >7 days Days Supply at First Fill 32 % 36 % 32 % Less than 3 Days Supply 3 7 Greater than 7

CDC Guidelines Guideline 1 Prescribe no more than needed Interesting: OxyContin made the top 10 for first prescriptions with 7+ days supply. Chronic pain patient with a new injury? New claim? DRUG % >7 DAYS HYDROCODONE/ACETAMINOPHEN/VICODIN 36.7% TRAMADOL HCL 35.0% OXYCODONE/ACETAMINOPHEN 8.9% TRAMADOL HYDROCHLORIDE/AC 5.6% ACETAMINOPHEN/CODEINE #3 4.6% OXYCODONE HCL 2.0% ACETAMINOPHEN/CODEINE PHO 1.9% HYDROCODONE BITARTRATE/AC 0.9% TRAMADOL HCL ER 0.8% OXYCONTIN 0.6%

CDC Guidelines Guideline 2 Use immediate release opioids to start Percent ER/LA at First Fill.2 %

CDC Guidelines Guideline 2 Use immediate release opioids to start Impact: Of long acting opioids used for the first prescription, 90% were Oxycontin DRUG % >7 DAYS OXYCONTIN 90% OPANA ER (CRUSH RESISTANT 4% HYSINGLA ER 2% OXYCODONE HCL ER 3% HYDROMORPHONE HCL ER 1%

CDC Guidelines Guideline 3 Assess risks with >50 MED and avoid >90 MED MED Calculation by Claimant 13.6 % 26.2 % 60.2 % MED % <50 MME 60.2% 50 90 MME 26.2% >90 13.6% <50 50 90 >90

CDC Guidelines Guideline 3 Assess risks Impact: Jump to 13.6% by CLAIMANT This highlights the importance of monitoring not just by drug and dosage but also the ENTIRE claim. 16.0% 14.0% 12.0% 10.0% 8.0% 6.0% 4.0% 2.0% 0.0% Fills vs Claimant 7.6% 13.6%

CDC Guidelines Guideline 4 Start low Go slow Do not prescribe ER/LA ER/LA vs Non ER/LA.3 %

CDC Guidelines Guideline 4 Start low, go slow Impact: Good news here only 0.3% of claimants received a long acting opioid in the first 30 days post injury..3% = 941 people

CDC Guidelines Guideline 5 Avoid concurrent benzodiazepine and opioids Concurrent Prescriptions 2.00.% 1.50% 1.00%.7% 0.50% 0.00%

CDC Guidelines Guideline 5 Avoid concurrent benzodiazepine and opioids Impact: Only 0.7% of those receiving an opioid were simultaneously prescribed a benzodiazepine 30% Deaths involving this combination

What s an Insurer to Do?

What Should Insurers Do? Challenges Physician Workload Enforcement State Regulations

What Should Insurers Do? Opportunities Monitoring Communications

What Should Insurers Do? Opportunities Critical Points Set Up - Formularies Early - First Fill During - Blocks, MED, Risk Calculation After - Managed Care

Impact What Matters

Questions